• Azithromycin in Bacterial Infection Research: Protocols & In

  2026-04-19

  Azithromycin, a 15-membered macrolide antibiotic, is pivotal for bacterial infection research and resistance modeling, with validated efficacy in both in vitro and animal trypanosomosis models. This article delivers practical protocols, troubleshooting strategies, and evidence-driven benchmarks to advance your experimental workflows with confidence.

• DGLA-Induced Ferroptosis via ACSL4 in AML: Mechanistic Insig

  2026-04-18

  This study reveals that exogenous dihomo-γ-linolenic acid (DGLA) triggers ferroptosis in acute myeloid leukemia (AML) cells through ACSL4-mediated lipid metabolic reprogramming. The findings highlight a novel therapeutic vulnerability in AML and provide a mechanistic link between lipid metabolism and non-apoptotic cell death, with implications for overcoming chemotherapy resistance.

• Chloroquine Diphosphate in Cancer Research: Autophagy Assay

  2026-04-17

  Chloroquine diphosphate empowers researchers to dissect autophagy and sensitize cancer cells to therapy through precise, reproducible workflows. Leverage its unique profile as a TLR7/9 inhibitor and autophagy modulator for robust, data-driven cancer research.

• PDHA1 Succinylation Drives Immune Evasion in Cholangiocarcin

  2026-04-16

  This study identifies succinylation of PDHA1 at lysine 83 as a key metabolic alteration in cholangiocarcinoma, leading to immune suppression via α-ketoglutaric acid accumulation and impaired macrophage antigen presentation. Targeting PDHA1 succinylation with CPI-613 sensitizes tumors to chemotherapy, revealing a promising approach to overcoming resistance.

• Phillygenin Mitigates Diabetic Nephropathy via Key Inflammat

  2026-04-15

  This study demonstrates that phillygenin, a Forsythia suspensa compound, alleviates diabetic nephropathy by suppressing inflammation and apoptosis in vitro and in vivo. The work uncovers how TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling regulation underlies phillygenin's renal protective effects, offering new molecular targets for diabetic kidney disease intervention.

• Wnt Agonist 1: Applied Workflows for Canonical Pathway Activ

  2026-04-14

  Wnt agonist 1 (BML-284) is a benchmark tool for precise activation of the canonical Wnt signaling pathway, powering advanced differentiation and chemoresistance research. This article delivers evidence-based protocols, troubleshooting strategies, and contextual guidance to maximize experimental success with APExBIO’s high-purity compound.

• Targeting BCL-XL in Glioblastoma: Insights from BH3-Mimetic

  2026-04-13

  This study reveals that glioblastoma (GBM) cells exhibit elevated apoptotic priming due to increased expression of anti-apoptotic BCL-2 family proteins, particularly BCL-XL and MCL-1. The research demonstrates that sequential inhibition of these proteins with BH3-mimetics induces robust tumor cell death, highlighting new therapeutic opportunities for resistant GBM.

• DMH1: Optimizing ALK2 Inhibition in Organoid and Cancer Mode

  2026-04-13

  DMH1, a selective ALK2 inhibitor, empowers researchers to fine-tune BMP signaling in advanced organoid and lung cancer workflows. Its unique specificity and robust solubility profile unlock both high-throughput stem cell modeling and targeted NSCLC studies—backed by APExBIO’s proven reliability.

• LDN-193189: Optimizing BMP Pathway Inhibition for Epithelial

  2026-04-12

  LDN-193189, a selective ALK inhibitor, unlocks high-fidelity control of BMP signaling for advanced epithelial cell culture, regenerative workflows, and disease modeling. Discover strategic protocol enhancements, troubleshooting tips, and practical insights from leading-edge studies to maximize the impact of this BMP signaling pathway inhibitor in your research.

• RepSox ALK5 Inhibitor: Optimizing iPSC Platelet Differentiat

  2026-04-12

  RepSox, a potent and selective ALK5 inhibitor, is revolutionizing induced pluripotent stem cell (iPSC) workflows by enabling rapid, cost-effective megakaryocyte and platelet production. This article translates recent experimental breakthroughs into actionable protocols, troubleshooting strategies, and advanced use-cases for cell differentiation and proliferation research.

• SAG: Smoothened Receptor Agonist for Advanced Hedgehog Pathw

  2026-04-11

  Smoothened Agonist (SAG) unlocks precise Hedgehog pathway activation for neuroprotection, tumorigenesis, and stem cell research. Leverage robust, literature-backed workflows and troubleshooting strategies to maximize reproducibility and translational value in both in vitro and in vivo models.

• Caspase-3 Colorimetric Assay Kit: Practical Protocol Guidanc

  2026-04-11

  The Caspase-3 Colorimetric Assay Kit (SKU K2008) provides a reliable method for quantifying DEVD-dependent caspase-3 activity, supporting apoptosis assays and related research. This kit is best utilized for cell lysate-based measurements where specificity and reproducibility are required; it is not recommended for applications lacking suitable controls or outside the caspase-3/caspase signaling pathway context.

• LDN193189 Hydrochloride: Protocols for BMP Pathway Inhibitio

  2026-04-10

  LDN193189 Hydrochloride is a potent ALK2 and ALK3 inhibitor used to study BMP signaling, epithelial barrier function, and bone formation disorders. It should be selected for experiments requiring precise inhibition of Smad1/5/8 phosphorylation but is unsuitable where off-target kinase inhibition or ethanol solubility is required.

• Chloroquine Diphosphate: Advanced Autophagy Modulation in...

  2026-04-10

  Explore the profound mechanisms of Chloroquine diphosphate as an autophagy modulator and TLR7/TLR9 inhibitor in cancer research. This article uniquely integrates the latest insights on autophagy-innate immunity crosstalk, cell cycle arrest, and therapeutic sensitization, offering a deeper analysis than existing resources.

• Crizotinib Hydrochloride (SKU B3608): Data-Driven Solutio...

  2026-04-09

  This article addresses real-world challenges in cell viability, proliferation, and cytotoxicity assays using Crizotinib hydrochloride (SKU B3608). Drawing on recent advances in assembloid modeling and kinase pathway interrogation, it provides scenario-based guidance for maximizing reproducibility and data quality with ATP-competitive inhibition strategies. Researchers will gain actionable, evidence-backed advice for integrating Crizotinib hydrochloride into advanced cancer biology workflows.

15883 records 1/1059 page Next 12345 下5页 Last page